Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis

Eric J Yang,1,2 Mary Patricia Smith,1,3 Karen Ly,1,4 Tina Bhutani1 1Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA; 3Icahn School of Medicine at Mount Si...

Full description

Bibliographic Details
Main Authors: Yang EJ, Smith MP, Ly K, Bhutani T
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Drug Design, Development and Therapy
Subjects:
biologics
guselkumab
IL-23 inhibitor
plaque psoriasis
biologic selection
Online Access:https://www.dovepress.com/evaluating-guselkumab-an-anti-il-23-antibody-for-the-treatment-of-plaq-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/evaluating-guselkumab-an-anti-il-23-antibody-for-the-treatment-of-plaq-peer-reviewed-article-DDDT

Similar Items